FRI-326 - Establishment of persistent functional remission of HBV and HDV infection following REP 2139 and pegylated interferon alpha 2a therapy in patients with chronic HBV/HDV co-infection: 18 month follow-up results from the REP 301-LTF study
| Autor: | Bazinet, M., Pantea, V., Cebotarescu, V., Cojuhari, L., Jimbei, P., Vaillant, A. |
|---|---|
| Zdroj: | In Journal of Hepatology April 2018 68 Supplement 1:S509-S509 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect